Maria Dall'Era, MD

2004 - Fellowship in Rheumatology, University of California, San Francisco
M.D., 1997 - School of Medicine, University of California, San Francisco
BA, 1993 - Immunology, University of California, Berkeley
Residency, - School of Medicine, University of California, San Francisco
Honors and Awards
  • Evelyn V. Hess Award, Lupus Foundation of America, 2023
  • Edmund L. Dubois Memorial Lectureship Award, American College of Rheumatology, 2018
  • Purple Ribbon Award, Lupus Foundation of America, 2014
  • Exceptional Physician Award, UCSF, 2010
  • Ira M. Goldstein Award for Outstanding Teaching in Rheumatology, UCSF, 2007
  • Ephraim Engleman Award for Excellence in Arthritis Research, UCSF, 2006
  1. Dall'Era M, Bruce IN, Gordon C, Manzi S, McCaffrey J, Lipsky PE. Current challenges in the development of new treatments for lupus. Annals of the rheumatic diseases 2019. PMID: 30636212

  2. Dall'Era M. Mycophenolate mofetil in the treatment of systemic lupus erythematosus. Current opinion in rheumatology 2011. PMID: 21720247

  3. Dall'era M, Chakravarty EF. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies. Current rheumatology reports 2011. PMID: 21584692

  4. Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Volume 63 of Issue 3. Arthritis care & research 2010. PMID: 21080348

  5. Dall'Era M, Chakravarty E, Wallace D, Genovese M, Weisman M, Kavanaugh A, Kalunian K, Dhar P, Vincent E, Pena-Rossi C, Wofsy D. Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Volume 56 of Issue 12. Arthritis and rheumatism 2007. PMID: 18050206